Skip to content
Titan Biotech logo

Titan Biotech

524717 BSE
Price unavailable

Titan Biotech (TITANBIO) share price was ₹352.00 at the 28 Oct 2026 close; sector Chemicals. The share price rose 96.4% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 27.3% year on year to ₹59.2 Cr and net profit was ₹11 Cr, against ₹7 Cr a year earlier (compared with Jun 2025). Promoters held 55.78% of Titan Biotech in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 57/100 (Good) as of 28 Oct 2026.

Close 28 Oct 2026 ₹352.00 +176.38 +100.43% 1Y

Key Fundamentals

MicrocapChemicals & PetrochemicalsChemicals
EBITDA
₹44.00 Cr
Return on Equity
15.12%
Debt to Equity
0.03
Book Value
₹35.15
EPS (TTM)
—
52W High
₹444.52
52W Low
₹137.12

Price-based figures as of 28 Oct 2026, 15:30 IST · TTM

Peer Comparison

Commodities › Chemicals › Specialty Chemicals

Pidilite Industries
₹1,368.2052.581,39,266 Cr12.871.48%22.36%28.48%15,689 Cr2,677 Cr
Gujarat Fluorochemicals
₹4,250.8077.1846,695 Cr5.970.07%7.25%10.13%5,334 Cr600 Cr
Navin Fluorine International
₹8,361.5054.2842,888 Cr10.800.18%16.70%18.66%3,734 Cr789 Cr
Aether Industries
₹1,573.6088.7520,886 Cr8.500.00%8.94%12.15%1,257 Cr235 Cr
Deepak Nitrite
₹1,483.1025.8220,228 Cr3.470.52%9.38%10.85%8,624 Cr784 Cr
Aarti Industries
₹457.4031.2416,585 Cr2.790.23%7.04%8.53%9,040 Cr531 Cr
Atul
₹5,154.5019.6615,176 Cr2.310.55%10.95%13.54%7,185 Cr788 Cr
Titan Biotech (this company)
——1,810 Cr10.010.15%15.12%20.80%225 Cr35 Cr
Median 8 companies₹1,573.6052.5820,557 Cr7.230.21%10.17%12.85%6,260 Cr692 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

57 Good
Overall score

Data confidence 95/100

Category scores

Quality Strong 83
Returns, margins, earnings quality 22% weight
Valuation Poor 22
Cheap vs sector & own history 24% weight
Growth Strong 94
Sales & profit trajectory 9% weight
Financial Health Strong 90
Solvency, leverage, coverage 9% weight
Momentum Average 49
Trend strength, vol-adjusted 12% weight
Ownership Average 51
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

2
  • Company is almost debt free.
  • Company is expected to give good quarter

Weaknesses

2
  • Stock is trading at 8.72 times its book value
  • The company has delivered a poor sales growth of 7.71% over past five years.

Technical Indicators

Oscillators

Neutral

Bearish
2
Neutral
5
Bullish
2

Overall

Bullish

Bearish
2
Neutral
5
Bullish
12

Moving Averages

Bullish

Bearish
0
Neutral
0
Bullish
10

Growth Rate

Revenue Growth
31.92% higher than 3Y

change over 1 year

Net Income Growth
49.73% higher than 3Y

change over 1 year

Cash Flow Change
51.19%

change over 1 year

EBITDA Margin Change
13.66%

change over 1 year Operating margin 21% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
35
43
46
40
43
40
38
35
46
54
57
49
59
Expenses
27
35
35
33
35
32
33
31
38
45
46
39
47
Operating Profit
8
9
11
7
8
8
5
5
9
9
11
10
12
OPM %
23%
20%
23%
18%
19%
19%
13%
13%
19%
17%
19%
20%
21%
Other Income
0
1
0
0
1
0
2
1
1
1
1
2
2
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
1
1
1
1
1
1
1
1
1
1
1
1
1
PBT
7
8
10
6
8
7
5
5
8
9
11
10
13
Tax %
24%
26%
26%
24%
24%
25%
26%
25%
24%
26%
26%
36%
26%
Net Profit
6
7
7
5
6
7
4
4
7
8
9
7
11
EPS (₹)
1.49
1.58
1.74
1.21
1.55
1.62
1.06
0.98
1.66
1.88
2.07
1.63
2.63
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
40
46
53
57
65
79
142
124
144
164
156
206
219
Expenses
36
42
47
50
56
66
96
92
114
130
131
168
176
Operating Profit
4
4
5
7
9
13
46
31
30
34
25
39
42
OPM %
10%
9%
10%
12%
14%
17%
32%
25%
21%
21%
16%
19%
19%
Other Income
0
1
0
0
1
1
0
1
2
2
4
5
6
Interest
1
1
1
2
2
2
2
1
1
1
1
1
1
Depreciation
1
1
1
1
2
2
2
2
3
3
4
5
5
PBT
2
3
3
4
6
10
43
29
28
32
24
38
43
Tax %
33%
34%
35%
35%
30%
25%
26%
25%
25%
25%
25%
28%
—
Net Profit
2
2
2
3
4
8
32
22
25
25
22
30
34
EPS (₹)
0.42
0.46
0.56
0.66
0.85
1.71
7.35
5.25
6.01
6.02
5.21
7.23
8.21
Div. Payout %
36%
33%
27%
23%
0%
12%
4%
6%
6%
7%
8%
7%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
8
8
8
8
8
8
8
8
8
8
8
8
Reserves
13
14
15
17
24
31
60
78
102
125
145
173
Borrowings
8
11
22
26
24
24
16
9
9
8
3
6
Other Liabilities
5
7
7
7
9
13
16
13
16
15
19
27
Total Liabilities
34
40
52
57
65
76
101
108
135
157
175
214
Fixed Assets
11
11
13
14
29
31
34
35
36
52
57
62
CWIP
1
5
9
13
0
0
0
4
13
3
2
2
Investments
0
0
0
0
0
0
0
4
15
28
33
60
Other Assets
21
24
30
30
36
45
67
65
70
74
83
90
Total Assets
34
40
52
57
65
76
101
108
135
157
175
214
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
-2
5
0
2
5
6
19
22
21
21
20
30
Investing
-3
-5
-8
-6
-4
-2
-5
-16
-21
-20
-10
-33
Financing
3
2
9
0
0
-4
-11
-4
-2
-3
-8
-2
Net Cash Flow
-2
2
1
-3
1
0
4
2
-2
-2
2
-4
Free Cash Flow
-3
0
-7
-4
1
8
14
8
8
12
12
23
CFO/OP
-28
143
21
43
74
62
65
93
97
85
103
101
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
58
47
44
49
52
54
46
48
53
42
44
40
Inventory Days
134
118
155
202
236
259
177
206
179
208
243
202
Days Payable
17
18
15
13
24
38
20
25
27
15
36
31
Cash Conversion Cycle
175
147
184
239
264
276
203
230
205
234
250
211
Working Capital Days
94
60
90
108
97
101
88
118
109
111
131
102
ROCE %
—
12%
12%
13%
15%
20%
58%
32%
27%
25%
17%
23%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Titan Biotech insights

60 extracted metrics + investor summaries across FY10–FY27.

Shareholding Pattern

DIIs0.01%Promot.55.78%Others16.05%Public28.16%As ofSep 2026

Documents

Frequently Asked Questions about Titan Biotech

What does Titan Biotech Ltd do?
Incorporated in 1992, Titan Biotech Ltd manufacturer and exporter of the Biological products[1]
Where is Titan Biotech Ltd (TITANBIO) listed?
Titan Biotech Ltd trades under code 524717 on the BSE.
Which sector does Titan Biotech Ltd belong to?
Titan Biotech Ltd is classified under the Chemicals sector, in the Specialty Chemicals industry.
What is the 52-week high and low of Titan Biotech Ltd?
Over the last 52 weeks Titan Biotech Ltd has traded between ₹137.12 and ₹444.52 as of 28 Oct 2026.
Does Titan Biotech Ltd pay dividends?
Titan Biotech Ltd has a dividend yield of 0.14%.
What is the Return on Equity (ROE) of Titan Biotech Ltd?
Titan Biotech Ltd reported a return on equity of 15.12%. Its debt-to-equity ratio is 0.03.

Company Information

Incorporated in 1992, Titan Biotech Ltd manufacturer and exporter of the Biological products[1]

Website titanbiotechltd.com
Face Value ₹ 2

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524717.md for Titan Biotech Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Chemical & Petrochemical stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month